English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The prognostic factors of patients with colorectal liver metastases (CLM) have been traditionally searched among the factors related to the primary colorectal tumor or to CLM. While many different scoring systems have been developed based on those traditional clinic-pathological factors, there has been the introduction of genetic biomarkers that added a theragnostic perspective. More recently, other important factors, such as those related to the host immune system, have been proposed as new determinants of prognosis of CLM patients. We herein review the current prognostic factors of CLM patients focusing on the burgeoning shifting paradigm of prognostication that relies on the host immune system.

Search for Theragnostic Biomarkers in Colorectal Liver Metastases: Focus on the Host Immune Cells